Scholar Rock Stock Shows Market Leadership With Healthy Jump To 83 RS Rating

When looking for the best stocks to buy and watch, focus on those with rising relative price strength. Scholar Rock stock fits that bill. Scholar Rock Holding (SRRK) had its Relative Strength Rating upgraded from 78 to 83 on Wednesday.


As you try to find the best stocks to buy and watch, be sure to pay attention to relative price strength.

This exclusive rating from Investor’s Business Daily measures market leadership with a 1 (worst) to 99 (best) score. The score shows how a stock’s price movement over the trailing 52 weeks compares to all the other stocks in our database.

History shows that the stocks that go on to make the biggest gains typically have an RS Rating north of 80 as they begin their biggest price moves.

Looking For Winning Stocks? Try This Simple Routine

Is Scholar Rock Stock A Buy?

Scholar Rock stock has climbed more than 5% past a 20.05 entry in a first-stage IPO base, meaning it’s now out of a proper buy zone. Look for Scholar Rock stock to offer a new chance to pick up shares like a three-weeks-tight pattern or a pullback to the 50-day or 10-week line.

The Cambridge, Mass.-based biopharma company reported negative growth for both sales and earnings last quarter. Scholar Rock is expected to report its next quarterly numbers on or around May 7.

Scholar Rock stock holds the No. 279 rank among its peers in the Medical-Biomed/Biotech industry group. Alexion Pharmaceuticals (ALXN) and Halozyme Therapeutics (HALO) are also among the group’s highest-rated stocks.


Find The Best Stocks To Buy Using IBD’s Proprietary Watchlists

MarketSmith’s Tools Can Help The Individual Investor

IBD Live: A New Tool For Daily Stock Market Analysis

Profit From Short-Term Trends With SwingTrader

IBD Stock Rating Upgrades: Rising Relative Strength

Most Related Links :
Business News Governmental News Finance News

Source link

Back to top button